In this episode of the Saving Lives Podcast, we dive into the DecatSepsis trial, exploring the role of dexmedetomidine in reducing mortality and managing septic shock. Discover how this sedative could help mitigate the harmful effects of the hyperadrenergic state in septic patients.

The Vasopressor & Inotrope Handbook

I have written "The Vasopressor & Inotrope Handbook: A Practical Guide for Healthcare Professionals," a must-read for anyone caring for critically ill patients (check out the reviews)! You have several options to get a physical copy. If you're in the US, you can order ⁠⁠A SIGNED & PERSONALIZED COPY for $29.99⁠⁠ or via ⁠⁠AMAZON for $32.99⁠⁠ (for orders in or outside the US). Ebook versions are available via ⁠⁠AMAZON KINDLE for $9.99⁠⁠, ⁠⁠APPLE BOOKS⁠⁠, and ⁠⁠GOOGLE PLAY⁠⁠. ¡Excelentes noticias! Mi libro ha sido traducido al español y está disponible a traves de ⁠⁠AMAZON⁠⁠. Las versiones electrónicas están disponibles para su compra for solo $9.99 en ⁠⁠AMAZON KINDLE⁠⁠, ⁠⁠APPLE BOOKS⁠⁠ y ⁠⁠GOOGLE PLAY⁠⁠.

Citation

Ezz Al-Regal AR, Ramzy EA, Allah Atia AA, Emara MM. Dexmedetomidine for Reducing Mortality in Patients With Septic Shock A Randomized Controlled Trial (DecatSepsis). Chest. 2024 Jul 14:S0012-3692(24)04601-4. doi: 10.1016/j.chest.2024.06.3794. Epub ahead of print. PMID: 39004217.